• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Vertebral Augmentation and Vertebroplasty Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018 - Product Image

Vertebral Augmentation and Vertebroplasty Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018

  • ID: 2258960
  • October 2012
  • Region: Global
  • 89 Pages
  • GlobalData

FEATURED COMPANIES

  • CareFusion
  • Medtronic Inc.
  • Stryker Corporation
  • MORE

Vertebral Augmentation and Vertebroplasty Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018

Summary

Our new report, “Vertebral Augmentation and Vertebroplasty Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018” provides key data, information and analysis on the global vertebral augmentation and vertebroplasty devices market. The report provides market landscape, competitive landscape and market trends information on the vertebral augmentation and vertebroplasty devices market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Our team of industry experts.

Scope

- Key geographies covered include the US, the UK, Germany, France, Italy, Spain and Japan.
- Key segments covered include vertebral augmentation and vertebroplasty devices.
- Annualized market revenues data READ MORE >

Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • CareFusion
  • Medtronic Inc.
  • Stryker Corporation
  • MORE

1
1

1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 GlobalData Report Guidance
3 Vertebral Compression Fractures - Overview
3.1 Epidemiology
3.2 Acute and Chronic Symptoms
3.3 Treatment Options for VCF
3.3.1 Benefits of Vertebral Augmentation over Vertebroplasty
3.3.2 Potential Complications
3.4 Treatment Flow Model for Vertebral Augmentation and Vertebroplasty Devices
4 Vertebral Augmentation and Vertebroplasty Devices: Global Market Characterization
4.1 Vertebral Augmentation and Vertebroplasty Devices Market, Global, Revenue ($m), Historic, 2004–2011
4.2 Vertebral Augmentation and Vertebroplasty Devices Market, Global, Revenue ($m), Forecast, 2011–2018
4.3 Vertebral Augmentation and Vertebroplasty Devices Market, Key Trends
4.3.1 Recovery of Kyphoplasty and Vertebroplasty Market from Negative Impact of New England Journal of Medicine Studies
4.3.2 Niche Status of Vertebral Augmentation Market with High Growth and Low Competition Provides a Great Opportunity for Orthopedic Device Manufacturers
4.3.3 Ongoing Studies Comparing the Effectiveness of Vertebral Augmentation and Vertebroplasty Techniques might decide the Course of Future Industry Growth
4.4 Global Vertebral Augmentation and Vertebroplasty Devices, Market Dynamics
4.4.1 Market Drivers
4.4.2 Market Restraints
5 Vertebral Augmentation and Vertebroplasty Devices Market, Analysis by Country, Revenue ($m), 2004 – 2018
5.1 Vertebral Augmentation and Vertebroplasty Devices Market, the US, Revenue ($m), Historic, 2004–2011
5.2 Vertebral Augmentation and Vertebroplasty Devices Market, the US, Revenue ($m), Forecast, 2011–2018
5.3 Vertebral Augmentation and Vertebroplasty Devices Market, the UK, Revenue ($m), Historic, 2004–2011
5.4 Vertebral Augmentation and Vertebroplasty Devices Market, the UK, Revenue ($m), Forecast, 2011–2018
5.5 Vertebral Augmentation and Vertebroplasty Devices Market, Germany, Revenue ($m), Historic, 2004–2011
5.6 Vertebral Augmentation and Vertebroplasty Devices Market, Germany, Revenue ($m), Forecast, 2011–2018
5.7 Vertebral Augmentation and Vertebroplasty Devices Market, France, Revenue ($m), Historic, 2004–2011
5.8 Vertebral Augmentation and Vertebroplasty Devices Market, France, Revenue ($m), Forecast, 2011–2018
5.9 Vertebral Augmentation and Vertebroplasty Devices Market, Italy, Revenue ($m), Historic, 2004–2011
5.10 Vertebral Augmentation and Vertebroplasty Devices Market, Italy, Revenue ($m), Forecast, 2011–2018
5.11 Vertebral Augmentation and Vertebroplasty Devices Market, Spain, Revenue ($m), Historic, 2004–2011
5.12 Vertebral Augmentation and Vertebroplasty Devices Market, Spain, Revenue ($m), Forecast, 2011–2018
5.13 Vertebral Augmentation and Vertebroplasty Devices Market, Japan, Revenue ($m), Historic, 2004–2011
5.14 Vertebral Augmentation and Vertebroplasty Devices Market, Japan, Revenue ($m), Forecast, 2011–2018
6 Vertebral Augmentation and Vertebroplasty Devices Market: Strategic Competitive Assessment
6.1 Vertebral Augmentation and Vertebroplasty Devices, Key Market Participants
6.1.1 Medtronic Inc.
6.1.2 Stryker Corporation
6.1.3 CareFusion
7 Vertebral Augmentation and Vertebroplasty Devices: Other Marketed Products
7.1 Confidence Spinal Cement System, Johnson & Johnson (DePuy/Synthes)
7.1.1 Product Description
7.2 Shield Kyphoplasty System, Soteira
7.2.1 Product Description
7.3 Kyphoplasty System, BONESUPPORT
7.3.1 Product Description
7.4 Acu-Cut Vertebral Augmentation System, Ascendx Spine
7.4.1 Product Description
7.5 V-MAX Delivery System, Johnson & Johnson (DePuy/Synthes)
7.5.1 Product Description
7.6 Integrated System for Vertebroplasty, Skeltex
7.6.1 Product Description
7.7 OsseoFix Spinal Fracture Reduction System, Alphatec Spine
7.7.1 Product Description
8 Vertebral Augmentation and Vertebroplasty Devices: Key Pipeline Products
8.1 Crosstrees Pod, Crosstrees Medical Inc.
8.1.1 Product Description
8.1.2 Product Status
8.2 Kiva VCF System, Benvenue Medical, Inc.
8.2.1 Product Description
8.2.2 Product Status
8.3 OsseoFix Spinal Fracture Reduction System, Alphatec Spine, Inc.
8.3.1 Product Description
8.3.2 Product Status
8.4 VerteLift Implant, SpineAlign Medical, Inc.
8.4.1 Product Description
8.4.2 Product Status
8.5 AVAMAX Vertebroplasty Kits, CareFusion
8.5.1 Product Description
8.5.2 Product Status
9 Vertebral Augmentation and Vertebroplasty Devices Market: Strategic Deals Analysis
9.1 List of Venture Financing Deals
9.2 List of Debt Offerings
9.3 List of Partnership Deals
9.4 List of Equity Offerings Deals
9.5 Key Deals
9.5.1 Ascendx Spine Entered into Co-Marketing Agreement with Anwerina
9.5.2 Benvenue Medical Raised $25m Series D Financing
9.5.3 Shanghai Kinetic Medical Completed IPO for $60m
10 Appendix
10.1 Market Definitions
10.1.1 Vertebral Augmentation and Vertebroplasty Devices
10.2 Acronyms
10.3 Sources
10.4 Research Methodology
10.4.1 Secondary Research
10.4.2 Primary Research
10.4.3 Models
10.4.4 Forecasts
10.4.5 Expert Panels
10.5 Consulting
10.6 Contact Us
10.7 Disclaimer

1.1 List of Tables
Table 1: VCF Prevalence in Cancer Patients
Table 2: Vertebral Augmentation and Vertebroplasty Devices Market, Global, Revenue ($m), 2004–2011
Table 3: Vertebral Augmentation and Vertebroplasty Devices Market, Global, Revenue ($m), 2011–2018
Table 4: Details of New England Journal of Medicine Studies on Vertebroplasty And Vertebral Augmentation Procedures, August 2009
Table 5: Global Procedure Volume for Vertebral Augmentation and Vertebroplasty, 2008–2010
Table 6: Global Kyphoplasty and Vertebroplasty Market Recovery Pattern, 2008–2011
Table 7: FREE (Fracture Reduction Evaluation), 2009
Table 8: FREE (Fracture Reduction Evaluation), 2011
Table 9: Cancer Patient Fracture Evaluation or CAFÉ, 2011
Table 10: Mortality Risk for Operated and Non-operated Vertebral Fracture Patients in the Medicare population or The SAVE study, 2011
Table 11: Three-year Outcomes after Kyphoplasty in Patients with Osteoporosis with Painful Vertebral Fractures , 2010
Table 12: Comparison of 5,766 Vertebral Compression Fractures Treated With or Without Kyphoplasty, 2010
Table 13: The Kiva System as a Vertebral Augmentation Treatment (KAST), Ongoing
Table 14: Balloon Kyphoplasty Versus Vertebroplasty for Treatment of Osteoporotic Vertebral Compression Fracture: a Prospective, Comparative and Randomized Clinical Study
Table 15: Adjacent Vertebral Fractures after Percutaneous Vertebral Augmentation of Osteoporotic Vertebral Compression Fracture: A Comparison of Balloon Kyphoplasty and Vertebroplasty, 2010
Table 16: Efficacy of Unipedicular Balloon Kyphoplasty for Treatment of Multiple Myeloma Vertebral Lesions, 2011
Table 17: Snapshot of New Diagnostic Technologies for Osteoporosis, 2010–2012
Table 18: Vertebral Augmentation Devices Market, Japan, Revenue ($m), Forecast, 2011–2018
Table 19: Procedure Cost Comparison, Vertebroplasty vs. Vertebral Augmentation, the US, 2007–2008
Table 20: Vertebral Augmentation and Vertebroplasty Devices Market, by Country, Europe, Revenue ($m), 2011
Table 21: Vertebral Augmentation and Vertebroplasty Devices Market, the US, Revenue ($m), 2004–2011
Table 22: Vertebral Augmentation and Vertebroplasty Devices Market, the US, Revenue ($m), 2011–2018
Table 23: Vertebral Augmentation and Vertebroplasty Devices Market, the UK, Revenue ($m), 2004–2011
Table 24: Vertebral Augmentation and Vertebroplasty Devices Market, the UK, Revenue ($m), 2011–2018
Table 25: Vertebral Augmentation and Vertebroplasty Devices Market, Germany, Revenue ($m), 2004–2011
Table 26: Vertebral Augmentation and Vertebroplasty Devices Market, Germany, Revenue ($m), 2011–2018
Table 27: Vertebral Augmentation and Vertebroplasty Devices Market, France, Revenue ($m), 2004–2011
Table 28: Vertebral Augmentation and Vertebroplasty Devices Market, France, Revenue ($m), 2011–2018
Table 29: Vertebral Augmentation and Vertebroplasty Devices Market, Italy, Revenue ($m), 2004–2011
Table 30: Vertebral Augmentation and Vertebroplasty Devices Market, Italy, Revenue ($m), 2011–2018
Table 31: Vertebral Augmentation and Vertebroplasty Devices Market, Spain, Revenue ($), 2004–2011
Table 32: Vertebral Augmentation and Vertebroplasty Devices Market, Spain, Revenue ($m), 2011–2018
Table 33: Vertebral Augmentation and Vertebroplasty Devices Market, Japan, Revenue ($m), 2004–2011
Table 34: Vertebral Augmentation and Vertebroplasty Devices Market, Japan, Revenue ($m), 2011–2018
Table 35: Vertebral Augmentation and Vertebroplasty Devices Market, Global, Company Share (%), 2011
Table 36: Medtronic, Key Marketed Products, 2012
Table 37: Kyphoplasty Settlements Between Hospitals and US Federal Government, 2009 - 2011
Table 38: Medtronic, Quarterly Revenue Decline from Core Spine, 2012
Table 39: Stryker, Key Marketed Products, 2012
Table 40: CareFusion, Key Marketed Products, 2012
Table 41: Vertebral Augmentation and Vertebroplasty Devices: Other Marketed Products
Table 42: Confidence Spinal Cement System, Description, 2011
Table 43: Shield Kyphoplasty System, Description, 2011
Table 44: Kyphoplasty System, Description, 2011
Table 45: Acu-Cut Vertebral Augmentation System, Description, 2011
Table 46: V-MAX Delivery System, Description, 2011
Table 47: Integrated System for Vertebroplasty (ISV), Description, 2011
Table 48: OsseoFix Spinal Fracture Reduction System, Description, 2010
Table 49: Vertebral Augmentation and Vertebroplasty Devices: Key Pipeline Products
Table 50: Crosstrees Pod, Status
Table 51: Kiva VCF System, Status
Table 52: OsseoFix Spinal Fracture Reduction System, Status
Table 53: VerteLift Implant
Table 54: AVAMAX Vertebroplasty Kits, Status
Table 55: Vertebral Augmentation and Vertebroplasty Devices Market, Key Strategic Deals Analysis, 2010–2012
Table 56: Vertebral Augmentation and Vertebroplasty Devices Market, Venture Financing Deals, 2010–2012
Table 57: Vertebral Augmentation and Vertebroplasty Devices Market, Debt Offerings, 2010–2012
Table 58: Vertebral Augmentation and Vertebroplasty Devices Market, Partnership Deals, 2010–2012
Table 59: Vertebral Augmentation and Vertebroplasty Devices Market, Equity Offering Deals, 2012

1.2 List of Figures
Figure 1: Vertebral Compression Fracture, Treatment Options
Figure 2: Treatment Flow Model: Vertebral Augmentation and Vertebroplasty Devices, Global, 2010
Figure 3: Vertebral Augmentation and Vertebroplasty Devices Market, Global, Revenue ($m), 2004–2011
Figure 4: Vertebral Augmentation and Vertebroplasty Devices Market, Global, Revenue ($m), 2011–2018
Figure 5: Global Procedure Volume for Vertebral Augmentation and Vertebroplasty, 2008–2010
Figure 6: Global Kyphoplasty and Vertebroplasty Market Recovery Pattern, 2008–2011
Figure 7: Global Vertebral Augmentation and Vertebroplasty Devices, Market Dynamics
Figure 8: Vertebral Augmentation Devices Market, Japan, Revenue ($m), Forecast, 2011–2018
Figure 9: Vertebral Augmentation and Vertebroplasty Devices Market, by Country, Europe, Revenue ($m), 2011
Figure 10: Vertebral Augmentation and Vertebroplasty Devices Market, the US, Revenue ($m), 2004–2011
Figure 11: Vertebral Augmentation and Vertebroplasty Devices Market, the US, Revenue ($m), 2011–2018
Figure 12: Vertebral Augmentation and Vertebroplasty Devices Market, the UK, Revenue ($m), 2004–2011
Figure 13: Vertebral Augmentation and Vertebroplasty Devices Market, the UK, Revenue ($m), 2011–2018
Figure 14: Vertebral Augmentation and Vertebroplasty Devices Market, Germany, Revenue ($m), 2004–2011
Figure 15: Vertebral Augmentation and Vertebroplasty Devices Market, Germany, Revenue ($m), 2011–2018
Figure 16: Vertebral Augmentation and Vertebroplasty Devices Market, France, Revenue ($m), 2004–2011
Figure 17: Vertebral Augmentation and Vertebroplasty Devices Market, France, Revenue ($m), 2011–2018
Figure 18: Vertebral Augmentation and Vertebroplasty Devices Market, Italy, Revenue ($m), 2004–2011
Figure 19: Vertebral Augmentation and Vertebroplasty Devices Market, Italy, Revenue ($m), 2011–2018
Figure 20: Vertebral Augmentation and Vertebroplasty Devices Market, Spain, Revenue ($m), 2004–2011
Figure 21: Vertebral Augmentation and Vertebroplasty Devices Market, Spain, Revenue ($m), 2011–2018
Figure 22: Vertebral Augmentation and Vertebroplasty Devices Market, Japan, Revenue ($m), 2004–2011
Figure 23: Vertebral Augmentation and Vertebroplasty Devices Market, Japan, Revenue ($m), 2011–2018
Figure 24: Vertebral Augmentation and Vertebroplasty Devices Market, Global, Company Share (%), 2011
Figure 25: Medtronic, SWOT Analysis
Figure 26: Medtronic, Quarterly Revenue Decline from Core Spine, 2012
Figure 27: Stryker, SWOT Analysis
Figure 28: CareFusion, SWOT Analysis
Figure 29: Vertebral Augmentation and Vertebroplasty Devices Market, Key Strategic Deals Analysis, 2010–2012

Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • CareFusion
  • Medtronic Inc.
  • Stryker Corporation
  • MORE

Not All Press is Good Press - Vertebral Augmentation and Vertebroplasty Market Makes Gradual Recovery From Public Slating

Reputation is everything in the medical devices market, as the slow recovery of vertebral augmentation and vertebroplasty procedures as an accepted treatment of spinal problems shows, states a new report by healthcare experts GlobalData.

The new report* studies the adverse impact on professional opinion caused by two academic studies, and depicts the risk that healthcare products face as a result of constant developments and investigations in the field.

Vertebral Compression Fractures (VCFs) can be treated using vertebral augmentation devices, also known as balloon kyphoplasty devices, and vertebroplasty devices. Both offer non-surgical treatment in outpatient settings, when conventional therapies such as rest, back bracing or drug-based therapies have not been effective, before physicians resort to invasive and expensive operations.

However, in August 2009, two studies were published in the New England Journal of Medicine (NEJM) questioning the benefits provided by vertebroplasty and vertebral augmentation procedures. These studies led physicians to favour alternative treatment options for VCFs, and prompted the American Association of Orthopedic Surgeons (AAOS) to strongly recommend against the use of vertebroplasty for VCF treatment. This in turn led some private insurers in the US to roll back their coverage policies for these procedures. The availability of reimbursements for vertebral augmentation procedures dramatically affects this medical market, as vertebral augmentation and vertebroplasty procedures are comparatively expensive to undertake.

These events crippled growth in the kyphoplasty and vertebroplasty market during 2009 and 2010, but the markets are now recovering from this damage. Growing doubts among physicians and specialists concerning the sample patient population considered by the two studies led to a number of new studies being published, which supported vertebroplasty and kyphoplasty procedures. Consequent recommendations from organizations such as the International Osteoporosis Foundation and Society of Interventional Radiology for the treatments helped in alleviating the bad press which kyphoplasty and vertebroplasty procedures had been given, and the market has shown a gradual recovery from 2010 onwards.

This case depicts the vital importance of clinical studies and academic research in the medical industry, as new findings can often not only help, but sometimes hinder, existing treatment options.

*Vertebral Augmentation and Vertebroplasty Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018

This report gives an overview of vertebral compression fracture, treatment modalities and major vertebral compression fracture treatment segments. Key segments covered include vertebral augmentation devices (referred as balloon kyphoplasty devices in some places) and vertebroplasty devices. The report also gives annualized market revenues data from 2004 to 2011, forecast forward for seven years to 2018, pipeline analysis split across different phases, and profiles of key products that are under clinical development.

This report was built using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis conducted by GlobalData’s team of industry experts.

Note: Product cover images may vary from those shown

Medtronic Inc.
Stryker Corporation
CareFusion

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos